[go: up one dir, main page]

TR201618568A2 - PARENTERAL CONTINUOUS EMISSION FORMULATION WITH IVERMEKTIN - Google Patents

PARENTERAL CONTINUOUS EMISSION FORMULATION WITH IVERMEKTIN Download PDF

Info

Publication number
TR201618568A2
TR201618568A2 TR2016/18568A TR201618568A TR201618568A2 TR 201618568 A2 TR201618568 A2 TR 201618568A2 TR 2016/18568 A TR2016/18568 A TR 2016/18568A TR 201618568 A TR201618568 A TR 201618568A TR 201618568 A2 TR201618568 A2 TR 201618568A2
Authority
TR
Turkey
Prior art keywords
parenteral
ivermektin
formulation
continuous emission
present
Prior art date
Application number
TR2016/18568A
Other languages
Turkish (tr)
Inventor
Takka Sevgi̇
Mi̇raç Kaya Süha
Original Assignee
Sevgi Takka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sevgi Takka filed Critical Sevgi Takka
Priority to TR2016/18568A priority Critical patent/TR201618568A2/en
Publication of TR201618568A2 publication Critical patent/TR201618568A2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluşun amacı sürekli salım sağlayan ivermektin içeren parenteral mikroküre formülasyonu geliştirmektir. Mevcut buluş, ivermektin, en az bir biyoparçalanabilir polimer ve yüzey aktif ajandan oluşan bir farmasötik kompozisyonu kapsamaktadır.The aim of the present invention is to develop a parenteral microsphere formulation containing sustained release ivermectin. The present invention includes a pharmaceutical composition comprising ivermectin, at least one biodegradable polymer and surfactant.

TR2016/18568A 2016-12-14 2016-12-14 PARENTERAL CONTINUOUS EMISSION FORMULATION WITH IVERMEKTIN TR201618568A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2016/18568A TR201618568A2 (en) 2016-12-14 2016-12-14 PARENTERAL CONTINUOUS EMISSION FORMULATION WITH IVERMEKTIN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2016/18568A TR201618568A2 (en) 2016-12-14 2016-12-14 PARENTERAL CONTINUOUS EMISSION FORMULATION WITH IVERMEKTIN

Publications (1)

Publication Number Publication Date
TR201618568A2 true TR201618568A2 (en) 2018-01-22

Family

ID=67980328

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2016/18568A TR201618568A2 (en) 2016-12-14 2016-12-14 PARENTERAL CONTINUOUS EMISSION FORMULATION WITH IVERMEKTIN

Country Status (1)

Country Link
TR (1) TR201618568A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230165798A1 (en) * 2018-10-12 2023-06-01 Hovione Scientia Macrocyclic lactone formulations, methods of their preparation and use of the formulations in treating pathologies secondary to ophthalmic parasites

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230165798A1 (en) * 2018-10-12 2023-06-01 Hovione Scientia Macrocyclic lactone formulations, methods of their preparation and use of the formulations in treating pathologies secondary to ophthalmic parasites

Similar Documents

Publication Publication Date Title
UY37341A (en) FORMULATIONS OF GAMMA-MODIFIED RELEASE HYDROXIBUTIRATE WITH IMPROVED PHARMACOCINETICS
CY1124037T1 (en) PREPARATION OF PEPTIDE LOADED PLGA MICROSPHERDS WITH CONTROLLED RELEASE CHARACTERISTICS
CL2016001032A1 (en) Support agents with improved dust control
CL2017003404A1 (en) Antibacterial compounds
BR112017007305A2 (en) fibrous structures with openings and methods for producing them
MX2019001437A (en) POLYPROPYLENE COMPOSITION WITH FLAME RETARDING ACTIVITY.
MX2020003841A (en) METHODS AND COMPOSITIONS FOR THE PRODUCTION OF NUCLEOSIDE TRIPHOSPHATES AND RIBONUCLEIC ACIDS.
SV2017005461A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
BR112015025561A2 (en) cosmetic formulation containing copolymer and sulfosuccinate and / or biotensive
MX2017004579A (en) Soluble fibrous structures and methods for making same.
MX377643B (en) Stabilizing agents and methods of use thereof
MX2019009126A (en) COMPOSITIONS AND METHODS FOR THE PROLONGED RELEASE OF GONADOTROPIN RELEASING HORMONE (GNRH) ANTAGONISTS.
MX2020002611A (en) Specific akt3 activator and uses thereof.
MX2016010169A (en) FORMULATION OF TABLET FOR ACTIVE PEPTIDE COMPOUNDS RELATED TO THE CALCITONINE GENE.
BR112015028377A2 (en) dialkyl 2,5-furandicarboxylate plasticizers and plasticized polymer compositions
AR105771A1 (en) FLAME RETARDING MATRIX
BR112018006103A2 (en) precision applicator
MX2019006291A (en) CALCIUM LACTATE COMPOSITIONS AND METHODS OF USE.
CO2018005753A2 (en) Hemostatic composition
BR112016009623A2 (en) alkali intumescent crosslinked acrylate copolymer, methods for making the same and composition comprising the same
MX2016014245A (en) COMPOSITIONS FOR CARE OF FABRICS THAT INCLUDE POLYURETHANE, POLYUREA AND / OR POLYURETHANEOUS POLYMERS.
DOP2015000033A (en) COMPOSITE MEMBER STRUCTURE FOR THE CONSTRUCTION OF MULTI FLOOR STRUCTURES
WO2014179615A3 (en) Biodegradable copolymers, forming and using same
CU24607B1 (en) STABLE SOLID, LYOPHILIZED, CONTAINING COPANLISIB, USEFUL FOR DILUTION AND THERAPEUTIC APPLICATIONS
BR112016007322A2 (en) compositions comprising polyamine polymer compatible perfume materials